Valet Health Shares Valet LaunchPad Product at Gener8tor OnRamp Healthcare Conference

GREEN BAY, Wis., June 21, 2019 /PRNewswire/ — On Wednesday, June 19, 2019, Valet Health, a healthcare predictive marketing company, attended the inaugural Gener8tor OnRamp Conference at Lambeau Field.  CEO Dave Bowen served as a panelist and moderator discussing topics around how technology can positively impact the delivery of healthcare.

This was an exciting time for Valet Health to introduce their new digital product, Valet LaunchPad, to the public. LaunchPad offers physicians and clinics a systematic way to effectively gather reviews from patients and boost their online reputation across health review and local sites. Review acquisition is just one benefit of the LaunchPad product, as it gives healthcare providers an automated way to communicate with patients.

As part of the panel on Caregiver and Clinician burnout, Dave Bown stated, “Online reputation and accuracy of information regarding provider profiles is critical in ensuring that patients are able to identify the appropriate physician for the health issue they are trying to address.” He went on to elaborate, “92% of patients go online prior to seeing a physician; it’s critical that providers take ownership of creating a clean and accurate depiction of the care they provide and how their patient experiences are documented through online reviews.”

About Valet Health: Valet Health’s role in emerging healthcare technology leverages the power of predictive analytics to efficiently acquire online reviews, capture high value patients, and educate existing patients. Valet Health specializes in developing and implementing digital programs with white-glove Valet service and turnkey support.

Media Contact: Kellie Mahon, 443-974-1190

View original content to download multimedia:http://www.prnewswire.com/news-releases/valet-health-shares-valet-launchpad-product-at-gener8tor-onramp-healthcare-conference-300872461.html

SOURCE Valet Health

Staff

Recent Posts

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

16 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

16 hours ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

16 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

16 hours ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

16 hours ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…

16 hours ago